Cardiovascular drugs
Cardiovascular drugs has been studied in 3 papers since 2022: 2 observational studies in people, 1 review; 1 in the past year. The newest paper, Feb 12, 2026: “Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study”.
3 papers study itUpdated
- Funder: National Institute on Aging
- Humans2
Funding
1 grant since 2019National Institute on AgingUS$2.2m
Latest
1 paper in 12 monthsCardiovascular Drugs and Therapy
Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study
Cohort study of 192,716 peopleMultimorbidity
Ageing Research Reviews
Fall risk-increasing drugs and gait performance in community-dwelling older adults: A systematic review
Systematic review of studies in peoplePopulations